Users

Atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology

Psychedelics7 hours ago

Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder

Psychedelics1 day ago

Psyence Group’s NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial

Psychedelics1 day ago

Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)

Psychedelics1 day ago

Going concern warnings cloud Xtacy Therapeutics’ shrunk losses

Law & Regulation1 day ago

Numinus reports declining revenue as the company restructures

Law & Regulation2 days ago

The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders

Psychedelics5 days ago

The EU’s Plan for a €6.5M Study of Psychedelics To Treat Mental Disorders

Psychedelics5 days ago

Indiana Advances Psilocybin Research with New Funding Initiative

Psychedelics5 days ago

Indiana Advances Psilocybin Research with New Funding Initiative

Psychedelics5 days ago